Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - sibnayal
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp1d09f2cdb23b1c4baeb1be5a4de77a38
identifier: http://ema.europa.eu/identifier
/EU/1/20/1517/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Sibnayal 8 mEq prolonged-release granules
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-1d09f2cdb23b1c4baeb1be5a4de77a38
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/20/1517/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - sibnayal
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
Sibnayal contains two active substances, potassium citrate and potassium hydrogen carbonate (also known as potassium bicarbonate).
Sibnayal is an alkalising medicine that is used to control blood acidity caused by a kidney disease called distal renal tubular acidosis (dRTA).
Sibnayal will help reduce the effect of dRTA on your everyday life.
Sibnayal is used in adults, adolescents and children above 1 year.
Do not take Sibnayal if:
Warnings and precautions
Talk to your doctor before taking Sibnayal if:
Sibnayal prolonged-release granules are designed to release the active substances slowly after taking the granules. You may see remains of the granules in your stools. This is normal and does not reduce the effectiveness of the medicine.
If you vomit within two hours after intake, you should take another dose.
You will need regular appointments with your doctor. From time to time, your doctor may need to do blood, urine or heart tests, to adjust the dose of Sibnayal. Your doctor will regularly check your kidney function if you are elderly and/or have worsening kidney function.
Children
Do not give this medicine to children below 1 year of age because of the risk of choking.
Other medicines and Sibnayal
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Some medicines may affect how Sibnayal works or make side effects more likely. These include:
any medicine that increases the level of potassium in your blood such as:
angiotensin-converting enzyme (ACE) inhibitors (used to treat high blood pressure, heart disease and kidney disease in patients suffering from type 1 diabetes),
potassium-sparing diuretics (used to treat high blood pressure, fluid build-up in tissue (oedema) and heart conditions),
potassium supplements (used to prevent or treat low potassium levels in the blood),
ciclosporin (used to prevent or treat transplant rejection),
heparin sodium (used to prevent or delay blood clotting),
nonsteroidal anti-inflammatory drugs (NSAIDs) (used to reduce fever, pain and inflammation),
any medicine that may be affected by a disturbance in the level of potassium in your blood such as:
digitalis glycosides (such as digoxin, used to treat heart failure and certain heart rhythm disorders),
corticosteroids (used to treat inflammation),
any other medicine that could cause heart rhythm disorders such as:
amiodarone and quinidine (used to control cardiac rhythm),
chlorpromazine (used to treat certain mental illnesses),
cisapride (used to treat heartburn),
sparfloxacin (used to treat certain bacterial infections).
Some medicines may be affected by increased urine pH in relation with Sibnayal treatment such as :
Sibnayal with food, drink and alcohol
Do not mix Sibnayal with hot food or hot liquids.
Do not drink alcohol while you are taking Sibnayal.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Sibnayal is not likely to affect your ability to drive or use machines.
Sibnayal contains potassium
Sibnayal 8 mEq contains 308 mg of potassium per sachet. This is to be taken into consideration if you have a reduced kidney function or if you are on a controlled potassium diet.
Sibnayal 24 mEq contains 924 mg of potassium per sachet. This is to be taken into consideration if you have a reduced kidney function or if you are on a controlled potassium diet.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The amount of Sibnayal that people have to take depends on their age, weight and condition. Your doctor will tell you exactly the dose of Sibnayal to take. This will always be one or more whole sachets.
Your doctor may need to adjust your dose of Sibnayal.
The use of this medicine requires medical supervision.
Dosage
The dose is adjusted by the doctor according to the level of bicarbonate in your blood.
How to use
Sibnayal is for oral use (to be taken by mouth). If you are not sure of how to use Sibnayal, contact your doctor or pharmacist.
Hold the sachet vertically with your fingers above the dotted line. Shake it from side to side to ensure the contents move to the bottom of the sachet.
Cut the sachet along the dotted line, using scissors if necessary.
Place all or part of the sachet contents directly into your mouth on your tongue.
Swallow the granules immediately with a large glass of water. Do not chew or crush the granules. Repeat steps 1 to 4 as required until you have taken the full dose.
For patients who are unable to swallow granules
Mix Sibnayal with small amounts of soft and cold food (e.g. fruit puree or yoghurt) directly on the spoon. You must swallow the soft food mixture immediately. Do not store the mixture for use later.
Place the mixture directly into the mouth and swallow it without chewing. Make sure that Sibnayal does not remain in the mouth. Repeat steps 1 and 2 as required until the full dose has been taken.
Do not mix the granules with liquid before taking them.
When to take Sibnayal
Take Sibnayal in the morning and in the evening, during a meal. You must leave an interval of about hours in between each dose to cover the whole night-and-day period.
Dose adjustment
Dose increases/decreases should be gradual, taking place over a few weeks. Your doctor will adjust the dose according to your condition. The usual recommended dose is 4 to 6 whole sachets of 24 mEq each day.
Please consult your doctor in the event of any side effects, as he / she may have to adjust the dose of this medicine.
Switch from another alkalising medicine
If you are switching from another alkalising medicines to Sibnayal, your doctor should closely supervise the switchover.
If you take more Sibnayal than you should
Talk to your doctor or pharmacist if you have taken more Sibnayal than you should have. You may feel nauseous, need to vomit and have diarrhoea. If you have taken a large amount of Sibnayal, you may feel weak or get unexplained tightness of the muscles, spasms (muscular contraction), abnormal tingling or burning sensations, pins and needles or numbness, mental confusion or an abnormal heart rate.
If you forget to take Sibnayal
Do not take a double dose to make up for a forgotten dose. Take it as soon as you remember. However, if your next dose is in less than six hours, skip the missed dose. Do not take more than two doses a day.
Talk to your doctor if you forget to take one or more doses.
If you stop taking Sibnayal
This medicine is for long-term use. It will only be effective as long as you are using it. Do not stop unless your doctor tells you to, even if you feel better, as your disease may get worse. If you want to stop treatment, first talk to your doctor.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects (which may affect more than 1 in 10 people)
Common side effects (which may affect up to 1 in 10 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the sachet and the carton after EXP. The expiry date refers to the last day of that month.
Do not store above 25 C.
After opening a sachet, discard any unused content.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Sibnayal contains
The active substances are potassium citrate and potassium hydrogen carbonate (also known as potassium bicarbonate).
Each sachet of Sibnayal 8 mEq contains 282 mg of potassium citrate and 527 mg of potassium hydrogen carbonate.
Each sachet of Sibnayal 24 mEq contains 847 mg of potassium citrate and 1,582 mg of potassium hydrogen carbonate.
The other ingredients are hypromellose (E464), microcrystalline cellulose (E460 (i)), glycerol dibehenate, magnesium stearate (E470b), silica colloidal anhydrous, magnesium oxide heavy (E530), ethylcellulose (E462), chlorophyllin (E140 (ii)), talc.
What Sibnayal looks like and contents of the pack
Sibnayal is a mixture of green and white prolonged-released granules supplied in sachets. Cartons contain 60 sachets.
Sibnayal is available in multipacks comprising 2, 3, 4, 5 and 6 cartons, each containing 60 sachets. Not all pack sizes may be marketed.
Marketing Authorisation Holder
ADVICENNE
262 rue du Faubourg Saint Honor
75008 Paris France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Belgi /Belgique/Belgien - Luxembourg/Luxemburg - Nederland TwinPharma BV Trasmolenlaan 5 3447 GZ Woerden Nederland T l/Tel: +31 348 71 24 e-mail: info@twinpharma.com
Italia SPA Societ Prodotti Antibiotici S.p.A. Tel: +39 02 891
ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Te .: +359 888 918 pv.global@exceedorphan.com
Magyarorsz g ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel.: +36 20 399 4pv.global@exceedorphan.com esk republika ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel: +420 608 076 pv.global@exceedorphan.com
Polska ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel.: +48 502 188 pv.global@exceedorphan.com Danmark - Norge - Suomi/Finland - Sverige Frostpharma AB Berga Backe 2 18253 Danderyd, Sverige
Tlf/Puh/Tel: + 46 8 243regulatory@frostpharma.com
Portugal Prospa Laborat rios Farmac uticos, S.A. Tel: +351 214171Deutschland - Eesti France
Ireland sland Latvija - Lietuva - Malta sterreich - United Kingdom (Northern Ireland) ADVICENNE 262 rue du Faubourg Saint Honor
75008 Paris, France Tel : + 33 1 85 73 36 Rom nia ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel: +40 744 366 pv.global@exceedorphan.com Espa a SPA farma Ib rica
Tel: + 34 622 273 Slovenija ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel: +386 30 210 pv.global@exceedorphan.com
Hrvatska ExCEEd Orphan Distribution d.o.o. Savska cesta 32, Zagreb, 100 Croatia Tel: +385 99 320 0pv.global@exceedorphan.com
Slovensk republika ExCEEd Orphan s.r.o. Bucharova 2657/12, Prague 5, 158 Czech republic Tel: +420 608 076 pv.global@exceedorphan.com
Manufacturer
ELAIAPHARM 2881 route des Cr tes ZI les Bouillides Sophia Antipolis
06560 Valbonne France
This leaflet was last revised in
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-1d09f2cdb23b1c4baeb1be5a4de77a38
Resource Composition:
Generated Narrative: Composition composition-en-1d09f2cdb23b1c4baeb1be5a4de77a38
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/20/1517/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - sibnayal
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp1d09f2cdb23b1c4baeb1be5a4de77a38
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp1d09f2cdb23b1c4baeb1be5a4de77a38
identifier:
http://ema.europa.eu/identifier
/EU/1/20/1517/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Sibnayal 8 mEq prolonged-release granules
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en